Background: Raised exhaled nitric oxide (FENO) levels have been associated with asthma. However, we have found that in children, FENO was increased in atopic children with increased airway responsiveness (AR), and this was independent of a diagnosis of asthma. Study objectives: The current study was designed to test the hypothesis that in adults there is no association between FENO and asthma after controlling for atopy and AR. 
xhaled nitric oxide (Feno) has been proposed as a noninvasive marker of airway inflammation in asthma. 1 Feno levels are elevated in asthmatics, 2 fall after treatment with corticosteroids, 3 and have been positively correlated with eosinophils in sputum 4 and BAL fluid. 5 These observations have prompted suggestions that measurement of Feno may be useful in the diagnosis and monitoring of asthma. 6 However, the nature of the relationship between raised Feno levels and both asthma and airway inflammation is incompletely understood. Indeed some studies have demonstrated discordance between Feno and changes in asthma symptoms, 7 and evidence of airway inflammation present in biopsy specimens. 8 Atopy is also associated with increased Feno, and there is now considerable evidence to demonstrate that atopy increases Feno independently of asthma. 9 -12 Recent studies, 13, 14 including ours, have shown that in children Feno is not elevated in all atopic individuals, but only in atopic children with increased airway responsiveness (AR). Interestingly, in our study, raised Feno identified individuals with atopy and increased AR regardless of a diagnosis of asthma or asthmatic symptoms. The aim of this study was to investigate the relationship between atopy, AR, and diagnosed asthma in adults.
Materials and Methods

Subjects and Protocol
Subjects for the present study were parents of children enrolled in a prospective birth cohort study of lung function, AR, and atopy. 15 This cohort was not selected on the basis of parental asthma. Parents had completed a modified American Thoracic Society questionnaire at enrollment, 16 and at the 11-year follow-up of the cohort they were invited to participate in an assessment that included spirometry, inhaled histamine challenge, skin-prick testing (SPT), blood eosinophil count, and measurement of Feno. Current and past respiratory symptoms were assessed using the same modified American Thoracic Society questionnaire, and the results were verified with previous records. An individual was considered to have current physiciandiagnosed asthma (PDA) following an affirmative response to the question, "do you currently have asthma diagnosed by a physician?" A history of PDA ever was said to be present if the respondent replied affirmatively to the question, "have you ever had asthma diagnosed by a physician?" Recent wheeze was said to be present if the respondent replied affirmatively to the question, "have you wheezed during the past year?" Current smoking was said to be present if the respondent replied affirmatively to the question, "do you currently smoke tobacco on a regular basis?" Assessments took place either at the home of the family or the hospital. Feno was measured only in those attending the hospital. None of the adults were symptomatic at the time of study. Written consent was provided by all subjects. The study was approved by the Medical Ethics Committee of Princess Margaret Hospital for Children.
FENO
Feno was measured using a fast-response chemiluminescence analyser (NOA 280; Sievers Instruments; Boulder, CO), as previously described. 10 Measurements were taken prior to spirometry and histamine challenge.
Pulmonary Function and AR
Pulmonary function testing was performed using a hand-held spirometer (Pneumocheck Spirometer 6100; Welch-Allyn; Skaneateles Falls, NY) in accordance with published guidelines. 17 AR to histamine was determined using the rapid dosimeter technique. 18 Increased AR was defined as a provocative dose of inhaled histamine causing a 20% fall in FEV 1 (PD 20 18 A dose-response slope (DRS) was also calculated using the method of O'Connor et al. 19 
SPT and Eosinophil Count
Skin reactivity to cow milk, egg white, rye grass, mixed grass, Dermatophagoides farinae, Dermatophagoides pteronyssinus, cat dander, dog dander, Alternaria alternans, and Aspergillus fumigatus (Hollister-Stier; Elkhart, IN) was assessed by SPT as described by Pepys. 20 The positive control was histamine sulfate (10 mg/mL), and the negative control was 0.9% saline solution. A positive SPT result was defined as a weal at least 3 mm in its longest dimension. Atopy was defined as the presence of at least one positive SPT finding. Blood was collected from the radial vein, and the blood eosinophil count was measured using a flow cytometer (Coulter Maxm; Beckman-Coulter; Fullerton, CA). Values are expressed as absolute cell count.
Statistical Analyses
Values for the DRS, Feno, and blood eosinophil count were skewed and were log 10 transformed prior to analysis to achieve a near-normal distribution (a constant of 1 was added to the DRS to allow values of Յ 0 to be included in the analysis). Univariate analyses using Student t test and simple linear regression were used to determine associations between transformed Feno and the following explanatory variables: current PDA, PDA ever, recent wheeze, atopy, DRS, blood eosinophils, height, gender, age, and FEV 1 . Due to the established differences between Feno for atopic and nonatopic subjects, separate multivariate regression models were constructed for both atopic and nonatopic individuals using transformed Feno values as the outcome variable. Factors that had a significance level of at least p Յ 0.1 from univariate analyses were included in these models. These were age, height, gender, history of PDA ever, current PDA, recent wheeze, DRS, current smoking, and atopy. Variables in all models were excluded in a backward step-wise fashion. Regression coefficients were log transformed back, and are reported as the fold difference between categorical variables, eg, symptoms, or fold increase per unit change in continuous variables. Feno levels, DRS, and blood eosinophil values are reported as geometric means with 95% confidence intervals (CIs). All analyses were performed using SPSS version 10.0.7 (SPSS; Chicago, IL).
Results
Two hundred forty-six study subjects underwent a respiratory assessment; however, only 115 attended the hospital where Feno concentrations were measured. These subjects are included in the analyses for this article. There were no differences between subjects with and without Feno measurements for age, gender, and proportion with asthma, atopy, and PD 20 Յ 7.8. Of the 115 subjects with Feno measurements, 77 were women and the mean age was 41 years (range, 31 to 56 years). The men (mean age, 43 years; SD 4) were older than the women (mean age, 39 years; SD 4) [p Ͻ 0.001]. Subject details are presented separately for men and women in Table 1 .
Feno measurements of two asthmatics treated with regular inhaled steroids were 10.9 ppb and 11.8 ppb, respectively, and due to known effects of inhaled corticosteroids on Feno, 21 these data were not included in analyses. SPT was performed in all of the remaining 113 individuals, bronchial challenge in 110 patients, spirometry in 112 patients, and eosinophil count in 112 patients. Seventy-eight study subjects (68%) were atopic, 31 subjects (26%) had a history of PDA ever, 20 subjects (18%) had current PDA, 25 subjects (22%) currently smoked, 19 subjects (17%) reported wheeze in the past 12 months, and 19 subjects (17%) had increased AR (Table 1) . Table 2 presents details of respiratory history, atopy, and AR for those subjects with and without PDA.
In the univariate analyses (Table 3) , there was a positive correlation between Feno and both age (r ϭ 0.22, p ϭ 0.02) and height (r ϭ 0.20, p ϭ 0.04). ( Table 5 , Fig 1) . There was no association between Feno and PDA, asthma ever, or recent wheeze in either model.
Discussion
We have previously reported an association, independent of asthma, between Feno and atopy and increased AR (as evidenced by DRS) among children. 14 In this study, we report a similar relationship between these variables for the parents of these children. In agreement with our findings in children, there was no association between Feno and past or current asthma symptoms or diagnosis in either atopic or nonatopic subjects after controlling for AR. This supports our previous proposition that Feno is associated with a common asthma phenotype, ie, atopy and increased AR, but not asthma per se.
Feno levels are raised in atopic but not nonatopic asthma, 12 and there is increasing evidence that the association between Feno and various characteristics of asthma, such as AR 9,12-14,22,23 and eosinophilia, 12, 13, 23 are dependent on atopy. The degree of atopy is also associated with Feno, with increasing levels of Feno reported with the number of positive SPT results in atopic children, 10, 24 and wheal responses to house dust mite allergen in adults. 11 The relationship between Feno and asthma symptoms, however, is not so clear. For example, we have shown that in children, that Feno is independent of asthma and asthma-like symptoms after controlling for both atopy and AR. 14 Similarly, Leuppi et al 9 found that, among atopic children with increased AR, there were no significant differences in Feno between those with and without wheeze. Conversely, Henriksen et al 25 found that suspected asthmatic adolescents with both atopy and increased AR had higher Feno levels than healthy subjects with a similar phenotype. Similarly, Steerenberg et al 13 found that Feno was associated with respiratory symptoms in atopic children. However, in that study it was unclear if the authors controlled for AR when investigating the association between Feno and symptoms. 13 The relationship between Feno and asthma is therefore complex, and the mechanism(s) for raised levels need further investigation. A potentially interesting finding in this study was a negative association between Feno and DRS in nonatopic subjects. This has not been previously reported. Due to the small number of nonatopics, we used Mahalanobis distance analysis to investigate whether this relationship was influenced by one or more influential data points. This did not appear to be the case; however, this observation should be interpreted with some caution and needs to be confirmed in other cohorts.
There was a small group of individuals with increased AR but not asthma. Asymptomatic increased AR is well described. 26 The clinical relevance of hyperreactivity in the absence of respiratory symptoms is not clear, but may be important to the natural history of lung function and the development of obstructive pulmonary disease. In children, asymptomatic increased AR is associated with reduced growth in lung function, 27 while in nonasthmatic adults, increased AR is associated with an accelerated decline in pulmonary function. 28 In this study, there was no relationship between peripheral blood eosinophil count and Feno, even in the atopic group. This contrasts with our findings 14 and those of others 29 in atopic children. Inconsistencies in the relationship between Feno and airway mucosal eosinophils between children 30 and adults 8 have also been reported. This suggests that mechanisms for Feno production may vary for different age groups. Although Feno is thought to reflect eosinophilic inflammation, 30 this relationship needs to be further elucidated.
Feno was higher in male than female subjects, and this relationship was independent of atopy. Other studies in adolescents 31 and adults [32] [33] [34] have also reported increased Feno levels in men compared with women. However, in young children 35 and infants, 36 girls have raised Feno levels compared with boys, while there appears to be no gender difference for older children. 10, 14, 31, 37 The trend for increased Feno for girls compared with boys but men compared with women is in direct contrast to the natural history of asthma, which predominates in boys compared with girls but is higher in women compared with men. 38 Our results suggest there is a maturational change in the relationship between Feno and gender. This could be due to relative changes in body mass 33 or differences in NO synthase activity between genders. 34 Regular tobacco smoking has been associated with reduced Feno 39 ; however, the present analysis suggests that this relationship may only be evident for atopic individuals. The reasons for this are unknown but may result from increased susceptibility of the atopic airway epithelium to environmental irritants 40 and consequent disruption of nitric oxide regulation.
Although this was an unselected population, there was a high prevalence of atopy among our subjects. This was unlikely to have influenced the outcomes for the analysis of atopic-only study subjects, but could have influenced the outcomes for nonatopic individuals where there were fewer individuals at risk for elevated Feno. Further, the adults in this study were the parents of the children we previously reported on. 14 Similar findings may therefore be the result of shared genetic and environmental factors between children and parents. The relationship between Feno and other variables reported in the present study should therefore be tested elsewhere.
In summary, we have confirmed in adults our findings in children of an interaction of Feno with atopy and increased AR. Importantly, asthma was not directly related to levels of Feno once this interaction was accounted for. Meaningful interpretation of Feno may only be possible when atopy and increased AR are considered.
